You are here

ImClone

Rough public start for biotech founded by ex-con, as CEO fumes at ‘vicious’ press

Stat

Wed, 07/27/16 - 02:49 pm

Banned ImClone founder plans IPO for new venture

CNBC

Wed, 09/24/14 - 07:56 am

ImClone’s Waksal Back in Biotech With Plans for Spinouts

Bloomberg

Tue, 09/3/13 - 10:45 am

Lilly's ImClone Purchase Pays Off

Forbes

Mon, 10/15/12 - 11:38 am

Bristol-Myers Approved to Market Erbitux for Wider Cancer Use

Bloomberg

Mon, 11/7/11 - 09:15 pm

Bristol-Myers Squibb

head and neck cancer

Changing the Perception of the Biotech One-Trick Pony

Seeking Alpha

Wed, 12/8/10 - 09:59 am

ONYX Pharmaceuticals

Erbitux May Not Help Colon-Cancer Survival for Some, Study Says .

WSJ

Sun, 06/6/10 - 11:10 am

ImClone Scandal: A Timeline

TheStreet.com

Tue, 02/16/10 - 02:25 pm

Bristol-Myers Squibb

ImClone Founder Waksal Forming New Biotech Venture

TheStreet.com

Tue, 02/16/10 - 10:40 am

insider trading

VC Financings Boost Interest in Biotech

Seeking Alpha

Fri, 07/24/09 - 09:41 am

venture capital

Human Genome Sciences

ONYX Pharmaceuticals

Bristol-Myers Squibb

Cell Therapeutics

One-Drug Wonders Deserve a Spot in Your Portfolio

Motley Fool

Tue, 06/30/09 - 03:36 pm

Gilead Sciences

CV Therapeutics

Cougar Biotechnology

Biopharma: Instead of M&A, Think P&A

Seeking Alpha

Thu, 03/5/09 - 08:19 am

Bristol-Myers Squibb

Vertex Pharmaceuticals

United Therapeutics

New Use for Erbitux Stalled by FDA’s Data Request

WSJ Online

Mon, 03/2/09 - 05:42 pm

Bristol-Myers Squibb

Lilly Reports $3.63 Billion Loss After ImClone Deal

Bloomberg

Thu, 01/29/09 - 07:26 am

ImClone, Bristol-Myers withdraw FDA application for Erbitux use in a type of lung cancer

Yahoo/AP

Sat, 01/24/09 - 10:28 am

Bristol-Myers Squibb

Lilly Files Form 8-K/A Detailing Pro Forma Impact of ImClone Acquisition

Yahoo

Tue, 01/13/09 - 06:07 am